Total Payments
$16,747
2024 Payments
$1,099
Companies
27
Transactions
229
Medicare Patients
4,139
Medicare Billing
$313,131
Payment Breakdown by Category
Food & Beverage$7,765 (46.4%)
Other$5,150 (30.8%)
Consulting$3,498 (20.9%)
Travel$333.57 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,765 | 218 | 46.4% |
| Honoraria | $4,400 | 6 | 26.3% |
| Consulting Fee | $3,498 | 2 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 1 | 4.5% |
| Travel and Lodging | $333.57 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $6,762 | 69 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,402 | 17 | $0 (2024) |
| Osprey Medical Inc | $2,269 | 33 | $0 (2020) |
| Datascope Corp. | $1,350 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $827.25 | 7 | $0 (2024) |
| Cardiovascular Systems Inc. | $705.46 | 17 | $0 (2022) |
| Abbott Laboratories | $672.45 | 11 | $0 (2023) |
| LivaNova USA, Inc. | $303.14 | 6 | $0 (2024) |
| Boston Scientific Corporation | $279.12 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $262.02 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,099 | 16 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($808.13) |
| 2023 | $323.53 | 8 | LivaNova USA, Inc. ($186.17) |
| 2022 | $3,658 | 39 | Datascope Corp. ($1,350) |
| 2021 | $579.49 | 27 | Novartis Pharmaceuticals Corporation ($119.10) |
| 2020 | $4,696 | 34 | ABIOMED ($3,526) |
| 2019 | $4,691 | 58 | AstraZeneca Pharmaceuticals LP ($2,158) |
| 2018 | $1,208 | 35 | ABIOMED ($598.67) |
| 2017 | $492.17 | 12 | Abbott Laboratories ($193.07) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.71 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/30/2024 | CORDIS US CORP. | MYNX CONTROL (Device) | Food and Beverage | In-kind items and services | $53.79 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/13/2024 | Stryker Corporation | N/A (Device) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: REPROCESSED VASCULAR | ||||||
| 03/06/2024 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2024 | LivaNova USA, Inc. | PROTEKDUO (Device) | Food and Beverage | In-kind items and services | $100.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/30/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/24/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $109.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/28/2023 | Boston Scientific Corporation | OptiCross (Device) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: OptiCross_IC | ||||||
| 07/12/2023 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Vascular | ||||||
| 06/30/2023 | Boston Scientific Corporation | OptiCross (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: OptiCross_IC | ||||||
| 05/17/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $46.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2023 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $74.89 | General |
| Category: Vascular | ||||||
| 12/13/2022 | Cardiovascular Systems Inc. | Diamondback Coronary (Device) | Food and Beverage | Cash or cash equivalent | $223.51 | General |
| Category: Atherectomy Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 976 | 1,259 | $233,524 | $77,472 |
| 2022 | 15 | 665 | 871 | $146,874 | $58,801 |
| 2021 | 14 | 858 | 1,108 | $200,336 | $72,740 |
| 2020 | 23 | 1,640 | 1,789 | $310,543 | $104,118 |
Total Patients
4,139
Total Services
5,027
Medicare Billing
$313,131
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 78 | 165 | $45,448 | $15,241 | 33.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 250 | 251 | $54,365 | $13,176 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 101 | $22,112 | $8,801 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 122 | $21,844 | $8,473 | 38.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 38 | $23,142 | $6,337 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $14,161 | $5,873 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 44 | 44 | $10,443 | $4,229 | 40.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $8,231 | $2,995 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 48 | $6,380 | $2,955 | 46.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $7,010 | $2,566 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,355 | $1,831 | 28.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 182 | 207 | $3,198 | $1,184 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 25 | $3,054 | $1,075 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 16 | $2,282 | $952.42 | 41.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 65 | $2,137 | $680.33 | 31.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $820.88 | $302.01 | 36.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 29 | 30 | $1,037 | $288.60 | 27.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 15 | $784.84 | $270.90 | 34.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 13 | 13 | $719.94 | $242.13 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 140 | $25,480 | $12,167 | 47.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 15 | 17 | $25,874 | $7,109 | 27.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 37 | 40 | $20,045 | $6,390 | 31.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 107 | 112 | $12,022 | $5,976 | 49.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 103 | $11,765 | $5,800 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $13,950 | $5,074 | 36.4% |
About Dr. Frank Amico, DO
Dr. Frank Amico, DO is a Cardiovascular Disease healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1497091904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Amico, DO has received a total of $16,747 in payments from pharmaceutical and medical device companies, with $1,099 received in 2024. These payments were reported across 229 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,765).
As a Medicare-enrolled provider, Amico has provided services to 4,139 Medicare beneficiaries, totaling 5,027 services with total Medicare billing of $313,131. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Advanced Heart Failure and Transplant Cardiology
- Location Chesapeake, VA
- Active Since 01/02/2013
- Last Updated 02/13/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497091904
Products in Payments
- Impella (Device) $6,762
- DyeVert (Device) $2,269
- CARDIOSAVE HYBRID, TYPE B PLUG (Device) $1,350
- LifeVest (Device) $827.25
- Diamondback Coronary (Device) $636.11
- ENTRESTO (Drug) $262.02
- LIFESPARC (Device) $202.32
- Circulatory Support (Device) $193.07
- FARXIGA (Drug) $175.23
- HeartMate PHP (Device) $166.57
- XARELTO (Drug) $146.69
- Optis Coronary Imaging System (Device) $122.64
- SYNERGY (Device) $121.20
- DIAMONDBACK CORONARY (Device) $102.52
- PROTEKDUO (Device) $100.82
- JARDIANCE (Drug) $92.55
- WOLVERINE (Device) $86.27
- Coronary Orbital Atherectomy System (Device) $69.35
- VRAYLAR (Drug) $66.43
- BRILINTA (Drug) $64.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chesapeake
Dr. John Herre, M.d, M.D
Cardiovascular Disease — Payments: $387,538
Cardiovascular Disease $387,538
Dr. Venkat Iyer, M.d, M.D
Cardiovascular Disease — Payments: $136,654
Cardiovascular Disease $136,654
Dr. Dhananjai Menzies, M.d, M.D
Cardiovascular Disease — Payments: $57,668
Cardiovascular Disease $57,668
Vadim Levin, M.d, M.D
Cardiovascular Disease — Payments: $32,111
Cardiovascular Disease $32,111
Mohsin Chowdhury, M.d, M.D
Cardiovascular Disease — Payments: $16,552
Cardiovascular Disease $16,552
Wayne Old, Md, MD
Cardiovascular Disease — Payments: $10,511
Cardiovascular Disease $10,511